When will be d dimer is significant at which value
D-dimer significant value threshold DVT PE diagnosis cutoff 2024
D-dimer cutoff threshold pulmonary embolism DVT diagnosis
D-dimer age-adjusted cutoff venous thromboembolism
HTTP 502 for https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?tool=orrisai&email=dev%40orris.ai&api_key=***&db=pubmed&term=%28D-dimer+age-adjusted+cutoff+venous+thromboembolism%29+NOT+%22Retracted+Publication%22%5Bpt%5D&retmode=json&retmax=3&sort=relevance&datetype=pdat&reldate=1095
We encountered an error while processing your request. Please try again or reach out to us for help.
Ddimer values ius 0.9 significant
D-dimer 0.9 mg/L significant DVT PE interpretation units
| Unit | Normal (Negative) | Your Value (0.9) | Interpretation |
|---|---|---|---|
| mg/L (FEU) | < 0.5 mg/L | 0.9 mg/L | ELEVATED - almost 2x the upper limit |
| µg/mL (FEU) | < 0.5 µg/mL | 0.9 µg/mL | ELEVATED |
| ng/mL (FEU) | < 500 ng/mL | 0.9 ng/mL | Normal (but this unit is unlikely for a result reported as "0.9") |
| DDU | < 250 ng/mL | -- | -- |
Most labs that report "0.9" are using mg/L or µg/mL, where the normal cutoff is 0.5. So 0.9 is 80% above the upper limit of normal.
Age-adjusted cutoff = Age × 10 ng/mL (or Age × 0.01 mg/L)
| Clinical Probability | D-dimer 0.9 → Next Step |
|---|---|
| Low / Intermediate | Further imaging required (Doppler ultrasound for DVT; CT pulmonary angiography for PE) |
| High | Go directly to imaging - do NOT rely on D-dimer to rule out |
What should we do
elevated D-dimer management algorithm next steps DVT PE workup guidelines
| Presentation | Suspected Diagnosis | Go to |
|---|---|---|
| Leg swelling, pain, redness | DVT | Wells DVT Score |
| Breathlessness, chest pain, low SpO2 | PE | Wells PE Score |
| No symptoms at all | Incidental elevation | Look for other causes |
| Feature | Points |
|---|---|
| Active cancer | +1 |
| Paralysis or recent immobilization of leg | +1 |
| Bedridden >3 days or major surgery <12 weeks | +1 |
| Tenderness along deep veins | +1 |
| Entire leg swollen | +1 |
| Calf swelling >3 cm vs other leg | +1 |
| Pitting edema confined to symptomatic leg | +1 |
| Collateral superficial veins | +1 |
| Alternative diagnosis as likely or more likely | -2 |
| Feature | Points |
|---|---|
| Clinical signs/symptoms of DVT | +3 |
| PE is #1 diagnosis OR equally likely | +3 |
| Heart rate > 100 bpm | +1.5 |
| Immobilization ≥3 days or surgery in past 4 weeks | +1.5 |
| Previous DVT or PE | +1.5 |
| Hemoptysis | +1 |
| Malignancy (on treatment, treated in last 6 months, palliative) | +1 |
D-dimer 0.9 (ELEVATED)
│
├── Low Clinical Probability (Wells low)
│ → Still elevated D-dimer = DO NOT ignore
│ → Proceed to imaging
│
├── Intermediate Clinical Probability
│ → Imaging MANDATORY
│
└── High Clinical Probability
→ Go directly to imaging
→ Start anticoagulation BEFORE imaging if delay expected
| Suspected Condition | First-Line Imaging |
|---|---|
| DVT | Compression Doppler Ultrasound of leg veins |
| PE | CT Pulmonary Angiography (CTPA) - gold standard |
| PE in pregnancy | V/Q scan preferred (less radiation) |
| Situation | Treatment |
|---|---|
| DVT / PE confirmed, hemodynamically stable | LMWH (e.g., Enoxaparin) + transition to oral anticoagulant (Rivaroxaban, Apixaban, or Warfarin) |
| Massive PE (hemodynamically unstable) | IV Unfractionated Heparin + consider thrombolysis |
| Cancer-associated VTE | LMWH preferred (e.g., Dalteparin) or Rivaroxaban/Apixaban |
| Pregnancy | LMWH only (warfarin and DOACs are contraindicated) |
D-dimer is a RULE-OUT test, not a RULE-IN test.
- Normal D-dimer = clot very unlikely (99% negative predictive value)
- Elevated D-dimer (like 0.9) = clot is POSSIBLE but NOT confirmed - imaging decides
Should we give clexane
Clexane enoxaparin DVT PE dose when to give indications contraindications guidelines
| Situation | Give Clexane? |
|---|---|
| DVT confirmed on ultrasound | YES |
| PE confirmed on CTPA | YES |
| High clinical probability, imaging delayed >few hours | YES - start empirically, don't wait |
| Elevated D-dimer alone (0.9), no symptoms, no diagnosis yet | NO - get imaging first |
| D-dimer elevated + high Wells score, waiting for scan | YES - start now, don't delay |
"The benefit of empiric anticoagulation for 24 hours exceeds the risks (bleeding and HIT) for any patient with a pretest probability of PE of >20%." "Delay in administration of heparin to patients with PE is associated with increased mortality."
| Indication | Dose | Route | Frequency |
|---|---|---|---|
| DVT/PE Treatment | 1 mg/kg | SC | Every 12 hours (BD) |
| DVT/PE Treatment (once daily) | 1.5 mg/kg | SC | Once daily |
| DVT/PE Prophylaxis (surgical, high risk) | 40 mg | SC | Once daily |
| Prophylaxis (moderate surgical risk) | 20 mg | SC | Once daily |
Example: 70 kg patient with DVT/PE = 70 mg SC every 12 hours (or 105 mg once daily)
| Condition | Adjustment |
|---|---|
| Renal impairment (eGFR < 30 mL/min) | Reduce to 1 mg/kg once daily - or switch to unfractionated heparin (UFH) |
| Severe renal failure | Prefer IV unfractionated heparin (easier to monitor and reverse) |
| Obesity (BMI > 40) | Use actual body weight, but consider anti-Xa monitoring |
| Pregnancy | Clexane is SAFE - preferred over warfarin/DOACs |
| Cancer patients | Clexane preferred over warfarin (better outcomes) |
| Absolute Contraindications | Relative Contraindications |
|---|---|
| Active major bleeding | Recent surgery (within 24-48 hrs) |
| Severe thrombocytopenia (platelets < 50,000) | High bleeding risk |
| History of HIT (Heparin-Induced Thrombocytopenia) | Uncontrolled hypertension |
| Hypersensitivity to enoxaparin | Severe liver disease |
After giving paracetamol injection how much time it takes to decrease temperature
IV paracetamol injection time to reduce fever onset of action antipyretic effect minutes
0 min ──── Infusion starts (given over 15 minutes)
│
15 min ─── Infusion complete
│
30 min ─── ✅ FEVER STARTS TO REDUCE
(TGA product data: "reduces fever within 30 minutes")
│
60 min ─── Peak antipyretic effect begins
(studies show significant temperature drop by 60 min)
│
1-2 hrs ── Maximum temperature reduction achieved
│
4-6 hrs ── Antipyretic effect lasts up to 6 hours
│
6 hrs ──── Next dose can be given if needed
| Parameter | IV Paracetamol (1g) |
|---|---|
| Onset of antipyretic effect | Within 30 minutes |
| Peak effect | 60-90 minutes |
| Duration of action | 4-6 hours |
| Full defervescence (median) | ~3 hours |
| Infusion time | 15 minutes |
| Dosing interval | Every 4-6 hours |
| Max daily dose (adult) | 4 g/day (4 doses of 1g) |
| Route | Onset of Fever Reduction |
|---|---|
| IV injection | ~30 minutes - fastest |
| Oral tablet/syrup | 45-60 minutes |
| Rectal suppository | 60-120 minutes - slowest |
What are the cause of fever in patient who is on chemotherapy
causes of fever in chemotherapy patient febrile neutropenia differential diagnosis oncology
| Criterion | Value |
|---|---|
| Fever | Single oral temp ≥ 38.3°C (101°F), OR ≥ 38.0°C (100.4°F) sustained over 60 min |
| Neutropenia | ANC < 500 cells/µL, OR ANC < 1000 and expected to fall to < 500 in 48 hrs |
⚠️ Important: Some neutropenic patients have serious infection WITHOUT fever - don't be falsely reassured by normal temp.
| Site | % of Cases |
|---|---|
| Lung (pneumonia) | 25% |
| Mouth and pharynx (mucositis) | 25% |
| GI tract | 15% |
| Skin, soft tissue, IV catheters | 15% |
| Perineum / anorectal | 10% |
| Urinary tract | 5% |
| Nose and sinuses | 5% |
Note: In 50% of cases, NO source of fever is found despite full workup.
| Cause | Notes |
|---|---|
| Drug fever (chemo itself) | Bleomycin, cytarabine, L-asparaginase are classic culprits |
| Drug allergy/hypersensitivity | Taxanes, platinum drugs, monoclonal antibodies |
| Tumor fever | Cancer itself (lymphoma, RCC, HCC) releases pyrogens |
| Transfusion reaction | After blood/platelets given |
| Pulmonary embolism (DVT/PE) | Cancer is hypercoagulable state |
| Graft vs. Host Disease (GVHD) | Post stem cell transplant |
| G-CSF administration | Filgrastim/pegfilgrastim cause bone pain + fever |
| Mucositis | Oral/GI breakdown from chemo allows bacterial entry |
Classic signs of infection are ABSENT in neutropenic patients - no pus, no swelling, minimal redness. Fever may be the ONLY sign. Never do rectal temperature or rectal examination in neutropenic patients - risk of bacterial translocation. Leukocytosis does NOT rule out neutropenia - patients on G-CSF (filgrastim) may show high WBC but still be functionally neutropenic. Start IV antibiotics within 60 minutes of arrival - IDSA/ASCO guideline.
INFECTION → Bacteria (Gram+ > Gram-)
→ Fungal (Candida, Aspergillus)
→ Viral (HSV, CMV, VZV)
→ Parasitic (PCP, Strongyloides)
NON-INFECT → Drug fever / allergy
→ Tumor fever
→ PE/DVT
→ Transfusion reaction
→ G-CSF
→ GVHD
Create a clinical management protocol for febrile neutropenia
febrile neutropenia clinical management protocol IDSA ASCO 2024 guidelines antibiotics MASCC
| Parameter | Threshold |
|---|---|
| Fever | Single oral temp ≥ 38.3°C (101°F), OR ≥ 38.0°C (100.4°F) sustained over 60 min |
| Neutropenia | ANC < 500 cells/µL, OR ANC < 1000 expected to drop to < 500 within 48 hrs |
⚠️ Never take rectal temperature in neutropenic patients (risk of bacterial translocation). ⚠️ Some neutropenic patients harbor serious infection without fever - treat unstable afebrile neutropenic patients the same way.
PATIENT PRESENTS WITH FEVER + KNOWN/SUSPECTED NEUTROPENIA
│
▼
┌─────────────────────────────┐
│ ALERT SENIOR DOCTOR NOW │
│ Call oncologist EARLY │
└─────────────────────────────┘
│
┌──────────────┼──────────────┐
▼ ▼ ▼
ASSESS BLOODS CULTURES
Vitals (see below) (before Abx)
| Site | What to Look For |
|---|---|
| Mouth/pharynx | Mucositis, ulcers, thrush, herpetic lesions |
| IV catheter sites | Redness, swelling, discharge |
| Perineum/anus | Tenderness (signs may be subtle - no pus in neutropenia) |
| Skin/nails | Cellulitis, fungal infection |
| Lungs | Reduced air entry, crackles |
| Sinuses | Tenderness, discharge |
| Feature | Points |
|---|---|
| Burden of illness: no or mild symptoms | 5 |
| Burden of illness: moderate symptoms | 3 |
| No hypotension (SBP > 90 mmHg) | 5 |
| No COPD | 4 |
| Solid tumor OR no previous fungal infection | 4 |
| No dehydration | 3 |
| Outpatient status at onset of fever | 3 |
| Age < 60 years | 2 |
| Maximum score | 26 |
| MASCC Score | Risk | Management |
|---|---|---|
| ≥ 21 | Low risk | Consider outpatient oral antibiotics (after 4 hrs observation) |
| < 21 | High risk | Admit - IV antibiotics mandatory |
| Drug | Dose | Route |
|---|---|---|
| Piperacillin-tazobactam (Tazocin) | 4.5 g every 6-8 hrs | IV |
| Cefepime | 2 g every 8 hrs | IV |
| Meropenem | 1 g every 8 hrs | IV |
| Imipenem-cilastatin | 500 mg every 6 hrs | IV |
Choose based on local antibiogram (institutional resistance patterns). Carbapenems preferred if local Pseudomonas resistance to cephalosporins is > 20%.
| Indication | Rationale |
|---|---|
| Suspected catheter-related infection (line site inflamed) | Gram-positive coverage |
| Known MRSA colonization | Targeted coverage |
| Haemodynamic instability / shock | Broadest coverage |
| Severe mucositis (viridans Strep risk) | High risk of Strep bacteraemia |
| On fluoroquinolone prophylaxis | Selection for resistant Gram-positives |
| Institution with high MRSA / Strep mitis rates | Local epidemiology |
| Allergy Type | Alternative |
|---|---|
| Minor penicillin allergy (rash only) | Cefepime or meropenem usually safe |
| Severe penicillin allergy (anaphylaxis) | Aztreonam + Vancomycin |
| Do NOT use fluoroquinolones as gram-negative cover in penicillin allergy | --- |
Do NOT start antifungal empirically without ID/oncology consultation in routine cases.
| Suspected Source | Additional Drug |
|---|---|
| Intra-abdominal / perianal | Add Metronidazole (if using cefepime - no anaerobic cover) |
| Atypical pneumonia | Add Azithromycin or Clarithromycin |
| HSV/VZV reactivation (oral ulcers, dermatomal rash) | Add Aciclovir IV |
| Influenza confirmed/suspected | Add Oseltamivir |
| PCP pneumonia (hypoxia, bilateral infiltrates, on steroids) | Add Co-trimoxazole (TMP-SMX) high dose |
Cultures POSITIVE?
├── YES → Narrow antibiotics to pathogen-directed therapy
└── NO → Continue empiric broad-spectrum antibiotics
Patient improving?
├── YES → Continue current Abx, reassess daily
└── NO → Broaden coverage (add antifungal, repeat imaging, ID consult)
| Condition | Action |
|---|---|
| ANC recovered to > 500 cells/µL AND afebrile > 48 hrs | Stop antibiotics (low-risk) |
| ANC still low but > 14 days with no identified infection | Consider stopping with ID guidance |
| Identified infection | Complete full course for that infection |
| Intervention | Details |
|---|---|
| G-CSF (Filgrastim/Pegfilgrastim) | Use if high-risk, prolonged neutropenia expected - reduces duration of neutropenia. NOT for routine fever treatment. |
| Antiemetics | Ondansetron for chemo-related nausea |
| Oral care / Mucositis | Chlorhexidine mouth rinses, benzydamine spray |
| IV fluids | Maintain hydration, especially if fever causing losses |
| Blood transfusion | If Hb < 7-8 g/dL (or symptomatic anaemia) |
| Platelet transfusion | If < 10,000/µL (or < 50,000 with active bleeding) |
| Isolation | Protective/reverse isolation - single room, HEPA filter if available |
| Diet | Low-microbial diet (avoid raw vegetables, unpasteurised food) |
| Intervention | Indication |
|---|---|
| G-CSF prophylaxis (Pegfilgrastim) | Chemo regimens with > 20% FN risk |
| Fluoroquinolone prophylaxis (Levofloxacin) | Expected ANC < 100 for > 7 days (haematological malignancies) |
| Antifungal prophylaxis (Fluconazole/Posaconazole) | High-risk (AML induction, stem cell transplant) |
| Antiviral prophylaxis (Aciclovir) | High-risk for HSV/VZV reactivation |
| PCP prophylaxis (Co-trimoxazole) | Prolonged steroid use, T-cell depletion |
| Vaccinations | Influenza yearly; Pneumococcal - before starting chemo |
FEVER in CHEMO PATIENT
│
▼
Take oral temp, check ANC
│
ANC < 500? ──YES──► FEBRILE NEUTROPENIA PROTOCOL
│
┌────▼────────────────────────────────────┐
│ Within 60 min: │
│ • Blood cultures (central + peripheral)│
│ • Urine culture │
│ • Bloods: FBC, U&E, LFT, lactate, CRP │
│ • CXR │
│ • Start IV Pip-Tazo / Cefepime │
└─────────────────────────────────────────┘
│
MASCC Score ≥21 + stable → Outpatient oral Abx (after 4hrs obs)
MASCC Score <21 / high-risk → ADMIT IV Abx
│
48-72 hrs: Review cultures, clinical response
│
ANC >500 + afebrile 48hrs → Consider stopping Abx
If he is associated with vomitings
febrile neutropenia vomiting management antiemetic IV fluids causes assessment oncology
| Cause | Clues |
|---|---|
| Chemotherapy-induced nausea/vomiting (CINV) | Vomiting started soon after last chemo cycle |
| Mucositis / esophagitis | Painful swallowing, oral ulcers |
| GI infection (Neutropenic enterocolitis / Typhlitis) | Right lower quadrant pain, diarrhea - EMERGENCY |
| C. difficile colitis | Watery diarrhea + vomiting, recent antibiotics |
| Sepsis-related vomiting | High fever, hypotension, confused |
| Drug reaction (to antibiotics, opioids) | Started after new medication |
| Raised intracranial pressure | Headache, projectile vomiting - CNS involvement |
| Electrolyte imbalance | Hyponatraemia, hypercalcaemia (tumour-related) |
| Bowel obstruction | Abdominal distension, no bowel sounds |
| Liver / biliary involvement | RUQ pain, jaundice |
| Opioid-induced | On strong opioids for pain |
Patient CANNOT take oral medications reliably → ADMIT and use IV antibiotics only This automatically removes the "low-risk / outpatient" option regardless of MASCC score.
IV LINE IN (preferably via existing central line)
│
├── Start IV Crystalloid (Normal Saline or Hartmann's)
│ • If mildly dehydrated: 1-2 L over 2-4 hours
│ • If hypotensive/septic: 30 mL/kg bolus FAST
│
└── Give all medications IV (antibiotics, antiemetics, paracetamol)
| Investigation | Reason |
|---|---|
| U&E + Serum Creatinine | Dehydration → AKI; electrolyte abnormalities causing vomiting |
| Serum Calcium | Hypercalcaemia (common in cancer - causes vomiting) |
| Serum Magnesium | Low Mg (from cisplatin chemo) worsens nausea |
| Abdominal X-ray / CT abdomen | Rule out bowel obstruction, typhlitis (thickened bowel wall) |
| LFTs + Bilirubin | Liver metastases, biliary sepsis |
| Stool C. difficile toxin | If diarrhea also present |
| Blood glucose | Hypoglycaemia can cause vomiting |
| Serum lactate | If vomiting + fever + hypotension → sepsis marker |
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Ondansetron (5-HT3 antagonist) | 8 mg IV every 8-12 hrs | IV slow push over 15 min | Drug of choice - safe, well tolerated |
| Metoclopramide | 10 mg IV every 8 hrs | IV | Also helps gastric emptying; avoid if bowel obstruction suspected |
| Drug | Dose | Route | Notes |
|---|---|---|---|
| Dexamethasone | 8 mg IV once or twice daily | IV | Very effective add-on - also reduces inflammation |
| Haloperidol | 0.5-1 mg IV/SC every 6-8 hrs | IV/SC | Useful for refractory nausea |
| Cyclizine | 50 mg IV/IM every 8 hrs | IV/IM | Good for opioid-induced vomiting |
| Lorazepam | 1 mg IV | IV | For anticipatory CINV or distressed patient |
Ondansetron + Dexamethasone + Aprepitant (NK1 antagonist)
| Intervention | Action |
|---|---|
| IV fluids | Correct dehydration - monitor input/output strictly |
| Electrolyte replacement | K+, Mg2+, Na+ replacement IV as needed |
| NBM (nil by mouth) | If severe vomiting or bowel obstruction suspected |
| NG tube | If vomiting uncontrolled or abdominal distension |
| Mouth care | Chlorhexidine rinses for mucositis |
| Monitor renal function | Dehydration + nephrotoxic antibiotics = AKI risk |
| Strict fluid balance | Chart every input and output hourly if unwell |
FEBRILE NEUTROPENIA + VOMITING
│
▼
┌─────────────────────────┐
│ ADMIT - no oral Abx │
│ IV access + IV fluids │
└─────────────────────────┘
│
┌─────────┴──────────┐
▼ ▼
IV ANTIBIOTICS IV ANTIEMETICS
(Pip-Tazo / (Ondansetron 8mg IV)
Cefepime) (+ Dexamethasone if needed)
│
▼
Extra bloods: U&E, Ca2+, Mg2+, Lactate, LFT
CT abdomen if abdominal pain (rule out typhlitis)
│
▼
Identify & treat CAUSE of vomiting
(CINV? Infection? Hypercalcaemia? Bowel pathology?)